Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Leukemia, Myeloid, Chronic-Phase
×
asciminib
×
Clear all
Filters
3
NCT03874858
2026-01-06
DANTE
Novartis
Phase 2
Completed
124 enrolled